MARKET

KZR

KZR

Kezar Life Sciences
NASDAQ
6.25
0.00
0.00%
Closed 15:59 12/05 EST
OPEN
6.19
PREV CLOSE
6.25
HIGH
6.27
LOW
6.19
VOLUME
40.31K
TURNOVER
--
52 WEEK HIGH
7.60
52 WEEK LOW
3.533
MARKET CAP
45.77M
P/E (TTM)
-0.7402
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KZR last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at KZR last week (1117-1121)?
Weekly Report · 11/24 10:10
Weekly Report: what happened at KZR last week (1110-1114)?
Weekly Report · 11/17 10:10
Kezar Life Sciences GAAP EPS of -$1.53 beats by $0.42
Seeking Alpha · 11/13 05:53
Kezar Life Sciences Reports Q3 2025 Financial Results
TipRanks · 11/13 04:21
Kezar Life Sciences Q3 EPS $(1.53) Beats $(2.08) Estimate
Benzinga · 11/12 21:33
Kezar Life Sciences posts narrower Q3 net loss, cuts workforce by 70%
Reuters · 11/12 21:10
Kezar Life Sciences reports Q3 EPS ($1.53), consensus ($1.96)
TipRanks · 11/12 21:05
More
About KZR
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases. The Company's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). The Company is focused on the development of zetomipzomib in autoimmune hepatitis, or AIH, a rare, chronic disease in which the immune system attacks the liver and causes inflammation and tissue damage. Its PORTOLA is a placebo-controlled, double-blind Phase IIa clinical trial of zetomipzomib in patients with AIH that were insufficiently responding to standard of care or have relapsed.

Webull offers Kezar Life Sciences Inc stock information, including NASDAQ: KZR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZR stock methods without spending real money on the virtual paper trading platform.